close 73% inwestorów detalicznych traci pieniądze podczas handlu CFD z tym dostawcą. Inwestowanie wiąże się z ryzykiem i nie jest odpowiednie dla wszystkich inwestorów. Kontrakty CFD są złożonymi instrumentami i wiążą się z dużym ryzykiem szybkiej utraty środków pieniężnych z powodu dźwigni finansowej. 73% rachunków inwestorów detalicznych notuje stratę pieniędzy podczas handlu kontraktami CFD z tym dostawcą. Upewnij się, czy rozumiesz, jak działają kontrakty CFD, i czy możesz pozwolić sobie na wysokie ryzyko utraty pieniędzy.
Change languagePolski
Pulpit

MDT

97.71

-2.09%↓

A

148.59

+1.08%↑

VEEV

241.39

-0.83%↓

HQY

95.25

-2.39%↓

PHR.US

17.19

+1.9%↑

MDT

97.71

-2.09%↓

A

148.59

+1.08%↑

VEEV

241.39

-0.83%↓

HQY

95.25

-2.39%↓

PHR.US

17.19

+1.9%↑

MDT

97.71

-2.09%↓

A

148.59

+1.08%↑

VEEV

241.39

-0.83%↓

HQY

95.25

-2.39%↓

PHR.US

17.19

+1.9%↑

MDT

97.71

-2.09%↓

A

148.59

+1.08%↑

VEEV

241.39

-0.83%↓

HQY

95.25

-2.39%↓

PHR.US

17.19

+1.9%↑

MDT

97.71

-2.09%↓

A

148.59

+1.08%↑

VEEV

241.39

-0.83%↓

HQY

95.25

-2.39%↓

PHR.US

17.19

+1.9%↑

Strona główna・Stock List・Karyopharm Therapeutics Inc
Search

Karyopharm Therapeutics Inc

Open

SectorHealthcare

8.81 13.68

Strong Buy

Price update 9 sty 2026, 16:21 UTC

BuySell

Overview

Share price change

24h

Current

Min

7.64

Max

8.52

Key metrics

By Trading Economics

Income

4.1M

-33M

Sales

6.1M

44M

EPS

-3.82

Profit margin

-75.213

Employees

279

EBITDA

1.8M

-23M

Recommendations

By TipRanks

Recommendations

Strong Buy

12 Months Forecast

+75.73% upside

Market Stats

By TradingEconomics

Market Cap

24M

126M

Previous open

-4.87

Previous close

8.81

News Sentiment

By Acuity

50%

50%

190 / 372 Ranking in Healthcare

Technical Score

By Trading Central

Confidence

Bullish Evidence

5.9501 / 7.66 Support & Resistance

Karyopharm Therapeutics Inc Chart

Wyniki osiągnięte w przeszłości nie są gwarantem przyszłych wyników.

Related News

8 sty 2026, 23:08 UTC

Acquisitions, Mergers, Takeovers

Rio Tinto, Glencore in Talks to Form World's Biggest Miner -- 3rd Update

DJ

Read

8 sty 2026, 21:39 UTC

Acquisitions, Mergers, Takeovers

Glencore, Rio Tinto Restart Merger Talks -- 2nd Update

DJ

Read

8 sty 2026, 20:54 UTC

Acquisitions, Mergers, Takeovers

Glencore, Rio Tinto Restart Merger Talks -- Update

DJ

Read

8 sty 2026, 20:44 UTC

Acquisitions, Mergers, Takeovers

Glencore, Rio Tinto Restart Merger Talks

DJ

Read

8 sty 2026, 17:05 UTC

Acquisitions, Mergers, Takeovers

Chinese Anta Sports Products Offers to Buy Pinault Family's Stake in Puma, Reuters Says, Citing Unnamed Sources

DJ

Read

8 sty 2026, 16:43 UTC

Major Market Movers

Babcock & Wilcox Shares Rise on Siemens Deal for Data Center Project

DJ

Read

8 sty 2026, 23:44 UTC

Market Talk

Nikkei May Rise on Weaker Yen -- Market Talk

DJ

Read

8 sty 2026, 23:37 UTC

Market Talk

Gold Steady, Underpinned by Geopolitical Risks -- Market Talk

DJ

Read

8 sty 2026, 22:42 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

DJ

Read

8 sty 2026, 22:42 UTC

Market Talk

RBA Still Battling a Troubling Inflation Outlook, Says TD -- Market Talk

DJ

Read

8 sty 2026, 22:30 UTC

Acquisitions, Mergers, Takeovers

Glencore, Rio Tinto Confirm Early Merger Talks -- Barrons.com

DJ

Read

8 sty 2026, 21:53 UTC

Earnings

These Stocks Moved the Most Today: Lockheed, Northrop, Alphabet, Applied Digital, Bloom Energy, Neogen, and More -- Barrons.com

DJ

Read

8 sty 2026, 21:50 UTC

Market Talk

Basic Materials Roundup: Market Talk

DJ

Read

8 sty 2026, 21:50 UTC

Market Talk

Auto & Transport Roundup: Market Talk

DJ

Read

8 sty 2026, 21:10 UTC

Acquisitions, Mergers, Takeovers

Rio Tinto Says Current Expectation That Any Deal Would Involve Buying Glencore Via Scheme of Arrangement

DJ

Read

8 sty 2026, 21:09 UTC

Market Talk

Oil Rises As Trump Said to Back Russia Sanctions Bill -- Market Talk

DJ

Read

8 sty 2026, 21:09 UTC

Acquisitions, Mergers, Takeovers

Rio Tinto Confirms in Talks With Glencore Over Possible Merger

DJ

Read

8 sty 2026, 20:21 UTC

Market Talk

U.S. Natural Gas Futures Down Despite Inventory Draw -- Market Talk

DJ

Read

8 sty 2026, 19:44 UTC

Market Talk

Gold's Shine Masks Deep Drops in Canada Steel, Aluminum Exports -- Market Talk

DJ

Read

8 sty 2026, 18:50 UTC

Market Talk

Mexico's Industrial Production Seen Lower in November -- Market Talk

DJ

Read

8 sty 2026, 17:48 UTC

Earnings

These Stocks Are Moving the Most Today: Lockheed, Northrop, Alphabet, Applied Digital, Bloom Energy, Neogen, and More -- Barrons.com

DJ

Read

8 sty 2026, 17:20 UTC

Market Talk

Basic Materials Roundup: Market Talk

DJ

Read

8 sty 2026, 17:20 UTC

Market Talk

Auto & Transport Roundup: Market Talk

DJ

Read

8 sty 2026, 17:20 UTC

Market Talk

Health Care Roundup: Market Talk

DJ

Read

8 sty 2026, 17:15 UTC

Market Talk

Global Commodities Roundup: Market Talk

DJ

Read

8 sty 2026, 16:45 UTC

Market Talk

Goldman Lifts 1H LME Copper Forecast -- Market Talk

DJ

Read

8 sty 2026, 16:03 UTC

Market Talk

Global Equities Roundup: Market Talk

DJ

Read

8 sty 2026, 16:03 UTC

Market Talk

Currency Markets Could Be Underpricing Medium-Term Risks -- Market Talk

DJ

Read

8 sty 2026, 16:02 UTC

Market Talk

U.S. Natural Gas Inventories Fall As Expected -- Market Talk

DJ

Read

8 sty 2026, 15:23 UTC

Acquisitions, Mergers, Takeovers

Paramount Defends Its Hostile Bid for Warner -- Update

DJ

Read

Peer Comparison

Price change

Karyopharm Therapeutics Inc Forecast

Price Target

By TipRanks

75.73% upside

12 Months Forecast

Average 13.83 USD  75.73%

High 21 USD

Low 6 USD

Based on 6 Wall Street analysts offering 12 month price targets forKaryopharm Therapeutics Inc - Dist in the last 3 months.

Rating Consensus

By TipRanks

Strong Buy

6 ratings

5

Buy

1

Hold

0

Sell

Based on 6 analysts giving stock ratings to Karyopharm Therapeutics Inc - Dist in the past 3 months.

Technical Score

By Trading Central

5.9501 / 7.66Support & Resistance

Short Term

Bullish Evidence

Recent bullish events outweigh bearish events.

Intermediate Term

Strong Bearish Evidence

All events are bearish.

Long Term

No Evidence

There are no events.

Sentiment

By Acuity

190 / 372 Ranking in Healthcare

News Sentiment

Neutral

Volatility

Below average

News Volume (RCV)

Below average

Financials

Selling and administration expenses

Operating expenses

Pre-tax profit

Sales

Cost of sales

Gross profit on sales

Interest expense on debt

EBITDA

Operating profit

$

Other stocks from the sector

MDT

Medtronic PLC

97.71

↓-2.09%

A

Agilent Technologies Inc

148.59

↑ +1.08%

VEEV

Veeva Systems Inc

241.39

↓-0.83%

HQY

HealthEquity Inc

95.25

↓-2.39%

PHR.US

Phreesia Inc

17.19

↑ +1.9%
help-icon Live chat